Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 3/20 | 0.36 |
| ▸ | TDO2 | P48775 | 2/20 | 0.36 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7727468 | 0.89 | KMT2A (0.39) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| SCHEMBL8943320 | 0.86 | CYP3A4 (0.42) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| SCHEMBL10615043 | 0.84 | TDP1 (0.54) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| SCHEMBL27873 | 0.84 | TDP1 (0.54) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| SCHEMBL27621561 | 0.81 | TDP1 (0.52) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| SCHEMBL8675665 | 0.81 | GABRA1 (0.46) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| Ethylene SCHEMBL10425506 | 0.79 | TDP1 (0.50) | MAPK1TDP1ALDH1A1CYP3A4TRPA1 | |
| SCHEMBL7172271 | 0.79 | ALDH1A1 (0.46) | MAPK1TDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL30102043 | 0.79 | ALDH1A1 (0.46) | MAPK1TDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL7172274 | 0.79 | ALDH1A1 (0.46) | MAPK1TDP1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 699 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240154124-A1 | NEGATIVE ELECTRODE PLATE AND LITHIUM-ION BATTERY COMPRISING SAME | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2024-05-09 | — | — | US | claimed |
| CN-111471171-B | Arylsulfonic acid intermediate, preparation method thereof and application of aryl sulfonic acid intermediate in synthesizing low-temperature-sensitivity additive for concrete | 江苏苏博特新材料股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-115385973-B | Application of oligonucleotide-tetrahydrothiazole compounds in synthesis of gene coding compound library | 康龙化成(宁波)科技发展有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-115385973-A | Application of oligo-nucleic acid-thiazolidine compound in synthesis of gene coding compound library | 康龙化成(宁波)科技发展有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-112961081-B | Bibenzamide urea compound and preparation method and application thereof | 山东第一医科大学(山东省医学科学院) | 2022-09-13 | — | — | CN | claimed |
| CN-110483569-B | Polycarbonate antioxidant, preparation method and polycarbonate composition | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-112961081-A | Bibenzamide urea compound and preparation method and application thereof | 山东第一医科大学(山东省医学科学院) | 2021-06-15 | — | — | CN | claimed |
| CN-107304214-B | Water-soluble ginkgolide B carbamate derivative and preparation method and application thereof | 浙江康恩贝制药股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| CN-111471171-A | Aryl sulfonic acid intermediate, preparation method thereof and application thereof in synthesizing low-temperature-sensitivity additive for concrete | 江苏苏博特新材料股份有限公司 | 2020-07-31 | — | — | CN | claimed |
| CN-107176925-B | Synthesis method of polysubstituted imidazoline-2, 4-diketone compound | 湖北科技学院 | 2020-04-28 | — | — | CN | claimed |
| CN-107176925-A | A kind of synthetic method of the cyclohexadione compounds of polysubstituted imidazoline 2,4 | 湖北科技学院 | 2017-09-19 | — | — | CN | claimed |
| US-8222314-B2 | Phenyl isocyanate-based urethane acrylates, processes for producing and methods of using the same | BAYER MATERIALSCIENCE AG (DE) | 2012-07-17 | — | — | US | claimed |
| CN-101704773-A | Phenyl isocyanate-based urethane acrylates, processes for making and methods of using the same | BAYER MATERIALSCIENCE AG | 2010-05-12 | — | — | CN | claimed |
| EP-2154128-A1 | Phenylisocyanate based urethanacrylates with high refraction index | Bayer MaterialScience AG (DE) | 2010-02-17 | — | — | EP | claimed |
| EP-2154129-A1 | Phenylisocyanate based urethanacrylate with high refraction index | Bayer MaterialScience AG (DE) | 2010-02-17 | — | — | EP | claimed |
| US-20100036013-A1 | PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME | BAYER MATERIALSCIENCE AG (DE) | 2010-02-11 | — | — | US | claimed |
| EP-1754705-A2 | Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders | Genentech, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-20260146238-A1 | UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION | PanTHERA CryoSolutions Inc. (CA) | 2026-05-28 | — | — | US | disclosed |
| US-3951976-A | 1-Thiadiazoly-6-carbamoyloxytetrahydropyrimidinones | VELSICOL CHEMICAL CORPORATION (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146238-A1 | UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION | RCC1, HNRNPC, CPT1A | MAPK1 1473/4885TDP1 518/4885ALDH1A1 49/4885 |
| US-20100036013-A1 | PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME | GRHPR, CBR1, C1S | MAPK1 681/4885TDP1 1202/4885ALDH1A1 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.